Advertisement

Intranasal Butorphanol May be a Treatment Option for Pruritus

Butorphanol is FDA-approved to treat migraine headaches, musculoskeletal pain, and postoperative pain. Researchers assessed whether intranasal butorphanol could be used as rescue...

Educational Program Describes Health Care Provider, Patient Gaps in Knowledge of Atopic Dermatitis

A study found that there are areas of miscommunication between health care professionals and patients/caregivers related to atopic dermatitis (AD) burden disease,...

Literature Review Indicates Addition of Topical Agent to Biologic Therapy Improves Efficacy for Psoriasis

Many psoriasis patients do not achieve complete skin clearance with biologic monotherapy. In a study, researchers assessed treatment approaches for patients who...

Study Finds Women are More Likely to Discontinue DMARD Therapy for Psoriasis, Psoriatic Arthritis

Researchers conducted a real-world study to assess gender differences in discontinuation, comorbidities, and comedications in patients with psoriasis and psoriatic arthritis (PsA)...
Advertisement